Jay Bhaumik Leads the Launch of Bio-Identical Hormone Pellets at Texas Star Pharmacy, Redefining Convenience and Consistency in HRT

Dr. Jay Bhaumik and Texas Star Pharmacy have introduced bio-identical hormone pellets as part of an ongoing commitment to evidence-based, patient-centered care.

PLANO, Texas--(BUSINESS WIRE)--Texas Star Pharmacy, a leader in customized compounding and patient-centered care, has announced the official launch of its new line of bio-identical hormone pellets. Spearheaded by Dr. Jay Bhaumik, the initiative marks a major advancement in hormone replacement therapy (HRT), offering patients a safer, more consistent, and convenient alternative to traditional modalities.

Designed to address growing demand from both prescribers and patients, the hormone pellets provide sustained therapeutic levels of hormones through a simple in-office procedure. The new offering is particularly valuable to busy professionals and individuals seeking to avoid the hassle of daily pills, creams, or injections.

“Our goal has always been to close the gap between innovation and patient care,” said Dr. Jay Bhaumik, CEO of Texas Star Pharmacy. “With bio-identical hormone pellets, we’re introducing a more effective, predictable, and lifestyle-compatible solution for hormone therapy.”

Texas Star Pharmacy’s pellets are manufactured using only plant-derived bio-identical hormones, ensuring hypoallergenic compatibility and optimal safety for both men and women. Each batch is compounded with validated precision using the Pellet Master Drug Formulary (MDF) and sourced from FDA-registered and ISO-certified facilities, guaranteeing consistent quality and efficacy.

Clinical validation of this therapy is well-established, with over a million documented procedures demonstrating low complication rates. Peer-reviewed sources, including PubMed and NCBI, reinforce the clinical benefits and predictability of bio-identical testosterone and estradiol pellet therapy, particularly in treating conditions like hypogonadism in men and perimenopause or post menopause symptoms in women.

Initial availability will begin with a limited release in July 2025, followed by full-scale access in October 2025. Texas Star Pharmacy’s commitment to integrating innovation with compassionate care continues to position the practice at the forefront of compounding pharmacies nationwide. With this new service, the pharmacy not only enhances its clinical offering but also supports physicians with consistent dosing and regulatory confidence.

Dr. Jay Bhaumik is a visionary leader in the healthcare industry with a distinguished career encompassing both clinical and executive roles at Yale University and Johns Hopkins. As the driving force behind Texas Star Pharmacy’s national recognition, he brings a unique blend of medical expertise and entrepreneurial acumen to advancing innovation in healthcare and technology.

Texas Star Pharmacy, based in Plano, TX, specializes in customized compounding solutions and personalized patient care. The pharmacy’s innovative approach ensures that every patient receives tailored healthcare solutions while maintaining competitive costs.

For more information about Texas Star Pharmacy, visit https://www.texasstarpharmacy.com/.